London-based private equity firm Alta Semper Capital has successfully raised $57.5 million in commitments for its Alta Semper Growth Fund II. The fund’s backing comes from major institutional investors, including the European Investment Bank (EIB) Group and the International Finance Corporation (IFC). This fundraising milestone underscores Alta Semper’s continued focus on healthcare and consumer investments in emerging markets.
Strong Institutional Support
The EIB Group, which encompasses both the European Investment Bank and the European Investment Fund, has committed $37.5 million to the new fund. The IFC has contributed an additional $20 million, highlighting robust confidence in Alta Semper’s strategy. Together, these partnerships represent a significant endorsement of the firm’s track record and its approach to mission-driven investing.
Fund Objectives and Strategy
Alta Semper Growth Fund II is targeting a total fund size of $150 million, aiming to scale healthcare and consumer businesses in Africa and select growth markets. The fund prioritizes sectors such as primary care, preventative medicine, diagnostics, medical devices, digital health, and consumer wellness platforms. It also seeks opportunities in disruptive technologies that can enhance access to affordable, high-quality products and services for underserved populations.
Early Investments
The firm has already begun deploying capital from Growth Fund II, with notable investments including MYDAWA, a leading digital health platform in East Africa. Another early portfolio addition is Allmed Group, a medical device company specializing in blood purification and renal care solutions. These initial investments demonstrate the fund’s commitment to driving tangible impact while supporting market-leading businesses.
Strategic Partnerships in Action
Alta Semper marked the funding milestone with a signing ceremony in Cairo, attended by representatives from the EIB, IFC, and MSMEDA, as well as Egyptian Minister Rania Al-Mashat and UK Ambassador Mark Bryson-Richardson. The event highlighted the collaborative approach underpinning the fund, emphasizing partnerships that foster entrepreneurship, job creation, and sustainable growth across the region. These relationships strengthen the fund’s ability to scale high-quality businesses and deepen its impact locally.
Leadership Perspective
Afsane Jetha, managing partner and CEO of Alta Semper, described the commitments as a strong validation of the firm’s investment philosophy. She emphasized that the partnerships would accelerate technology adoption, enhance healthcare delivery, and contribute to building resilient, equitable health ecosystems. Jetha also highlighted the dual objective of delivering meaningful social impact while generating attractive returns for investors.
Looking Ahead
With the momentum from this initial closing, Alta Semper Growth Fund II is well-positioned to reach its $150 million target. The fund plans to continue identifying and supporting innovative companies that can transform healthcare and consumer sectors across emerging markets. As the firm deploys additional capital, it aims to create measurable outcomes for communities while maintaining strong financial performance.
Alta Semper’s successful fundraising reflects growing investor interest in mission-driven private equity in Africa and the Middle East. By combining institutional support with a targeted investment strategy, the firm is advancing its vision of scalable, technology-enabled healthcare solutions. Growth Fund II represents both a financial and societal opportunity, reinforcing Alta Semper’s role as a catalyst for impactful investment in high-growth markets.